Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US
Keyword(s):
Keyword(s):
2015 ◽
Vol 66
(15)
◽
pp. B297
◽
2015 ◽
Vol 37
(11)
◽
pp. 2476-2488.e27
◽
2015 ◽
Vol 37
(12)
◽
pp. 2837-2851
◽
2015 ◽
Vol 8
(2_suppl_1)
◽
pp. S12-S20
◽
2014 ◽
Vol 33
(9)
◽
pp. 535-544
◽
2017 ◽
Vol 34
(1)
◽
pp. 55-63
◽
2017 ◽
Vol 130
(4)
◽
pp. 434-438
◽